Nuvectis Pharma, Inc. cotiza a 18.15 USD y tiene una capitalización bursátil de $592M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-o…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.30 | $-0.26 | $-0.31 |
| Estimado | $-0.24 | $-0.26 | $-0.31 | $-0.31 |
| Sorpresa | — | -15.4% | +16.1% | +0.0% |
| Métrica | NVCT | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -143.6% | -40.4% | -103.2% |
| ROA | -83.4% | -32.0% | -51.4% |
| Current Ratio | 2.38 | 2.84 | -0.46 |
| Debt / Equity | — | 0.28 | — |